Abstract
The Helicase-like Transcription Factor (HLTF) belongs to the SWI/SNF family of proteins involved in chromatin remodeling. In addition to its role in gene transcription, HLTF has been implicated in DNA repair, which suggests that this protein acts as a tumor suppressor. Accumulating evidence indicates that HLTF expression is altered in various cancers via two mechanisms: gene silencing through promoter hypermethylation or alternative mRNA splicing, which leads to the expression of truncated proteins that lack DNA repair domains. In either case, the alteration of HLTF expression in cancer has a poor prognosis. In this review, we gathered published clinical and molecular data on HLTF. Our purposes are (a) to address whether HLTF alterations could be considered as cancer drivers or passengers and (b) to determine whether its different functions (transcription or DNA repair) could be diverted in clonal selection during cancer progression.
Similar content being viewed by others
References
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Aguilera A, García-Muse T (2013) Causes of genome instability. Annu Rev Genet 47:1–32
Gatenby RA, Cunningham JJ, Brown JS (2014) Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations. Nat Commun 5:5499
Sheridan PL, Schorpp M, Voz ML, Jones KA (1995) Cloning of an SNF2/SWI2-related protein that binds specifically to the SPH motifs of the SV40 enhancer and to the HIV-1 promoter. J Biol Chem 270:4575–4587
Lin Y, Sheridan PL, Jones KA, Evans GA (1995) The HIP116 SNF2/SW12-related transcription factor gene (SNF2L3) is located on human chromosome 3q25.1-q26.1. Genomics 27:381–382
Hayward-Lester A, Hewetson A, Beale EG, Oefner PJ, Doris PA, Chilton BS (1996) Cloning, characterization, and steroid-dependent posttranscriptional processing of RUSH-1 alpha and beta, two uteroglobin promoter-binding proteins. Mol Endocrinol Baltim Md 10:1335–1349
Zhang Q, Ekhterae D, Kim KH (1997) Molecular cloning and characterization of P113, a mouse SNF2/SWI2-related transcription factor. Gene 202:31–37
Gong X, Kaushal S, Ceccarelli E, Bogdanova N, Neville C, Nguyen T, Clark H, Khatib ZA, Valentine M, Look AT et al (1997) Developmental regulation of Zbu1, a DNA-binding member of the SWI2/SNF2 family. Dev Biol 183:166–182
Ding H, Descheemaeker K, Marynen P, Nelles L, Carvalho T, Carmo-Fonseca M, Collen D, Belayew A (1996) Characterization of a helicase-like transcription factor involved in the expression of the human plasminogen activator inhibitor-1 gene. DNA Cell Biol 15:429–442
Capouillez A, Decaestecker C, Filleul O, Chevalier D, Coppée F, Leroy X, Belayew A, Saussez S (2008) Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Arch Int J Pathol 453:491–499
Aguilera A, García-Muse T (2013) Causes of genome instability. Annu Rev Genet 47:1–32
Unk I, Hajdú I, Blastyák A, Haracska L (2010) Role of yeast Rad5 and its human orthologs, HLTF and SHPRH in DNA damage tolerance. DNA Repair 9:257–267
Moinova HR, Chen W-D, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R et al (2002) HLTF gene silencing in human colon cancer. Proc Natl Acad Sci USA 99:4562–4567
Capouillez A, Debauve G, Decaestecker C, Filleul O, Chevalier D, Mortuaire G, Coppée F, Leroy X, Belayew A, Saussez S (2009) The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology 55:77–90
Capouillez A, Noël J-C, Arafa M, Arcolia V, Mouallif M, Guenin S, Delvenne P, Belayew A, Saussez S (2011) Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression. Histopathology 58:984–988
Hewetson A, Chilton BS (2003) An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. J Biol Chem 278:40177–40185
Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6:597–610
Kim JM, Cho EN, Kwon YE, Bae SJ, Kim M, Seol JH (2010) CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions. Biochem Biophys Res Commun 395:515–520
Qing P, Han L, Bin L, Yan L, Ping WX (2011) USP7 regulates the stability and function of HLTF through deubiquitination. J Cell Biochem 112:3856–3862
Hewetson A, Chilton BS (2008) Progesterone-dependent deoxyribonucleic acid looping between RUSH/SMARCA3 and Egr-1 mediates repression by c-Rel. Mol Endocrinol Baltim Md 22:813–822
Visser M, Kayser M, Palstra R-J (2012) HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. Genome Res 22:446–455
Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinforma Oxf Engl 21:2933–2942
Helmer RA, Foreman O, Dertien JS, Panchoo M, Bhakta SM, Chilton BS (2013) Role of helicase-like transcription factor (hltf) in the G2/m transition and apoptosis in brain. PLoS ONE 8:e66799
Helmer RA, Dertien JS, Chilton BS (2011) Prolactin induces Jak2 phosphorylation of RUSHY195. Mol Cell Endocrinol 338:79–83
Guillaumond F, Boyer B, Becquet D, Guillen S, Kuhn L, Garin J, Belghazi M, Bosler O, Franc J-L, François-Bellan A-M (2011) Chromatin remodeling as a mechanism for circadian prolactin transcription: rhythmic NONO and SFPQ recruitment to HLTF. FASEB. J Off Publ Fed Am Soc Exp Biol 25:2740–2756
Hewetson A, Chilton BS (2008) Progesterone-dependent deoxyribonucleic acid looping between RUSH/SMARCA3 and Egr-1 mediates repression by c-Rel. Mol Endocrinol Baltim Md 22:813–822
Helmer RA, Martínez-Zaguilán R, Dertien JS, Fulford C, Foreman O, Peiris V, Chilton BS (2013) Helicase-like transcription factor (hltf) regulates g2/m transition, wt1/gata4/hif-1a cardiac transcription networks, and collagen biogenesis. PLoS ONE 8:e80461
Tian F, Sharma S, Zou J, Lin S-Y, Wang B, Rezvani K, Wang H, Parvin JD, Ludwig T, Canman CE et al (2013) BRCA1 promotes the ubiquitination of PCNA and recruitment of translesion polymerases in response to replication blockade. Proc Natl Acad Sci USA 110:13558–13563
Brys R, Nelles L, van der Schueren E, Silvestre N, Huylebroeck D, Remacle JE (1998) Identical cis-acting elements and related trans-acting factors control activity of nonviral promoter in Schizosaccharomyces pombe and mammalian cells. DNA Cell Biol 17:349–358
Ding H, Beckers MC, Plaisance S, Marynen P, Collen D, Belayew A (1998) Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements. Hum Mol Genet 7:1681–1694
Mahajan MC, Weissman SM (2002) DNA-dependent adenosine triphosphatase (helicaselike transcription factor) activates beta-globin transcription in K562 cells. Blood 99:348–356
Ding H, Benotmane AM, Suske G, Collen D, Belayew A (1999) Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene. J Biol Chem 274:19573–19580
Hewetson A, Hendrix EC, Mansharamani M, Lee VH, Chilton BS (2002) Identification of the RUSH consensus-binding site by cyclic amplification and selection of targets: demonstration that RUSH mediates the ability of prolactin to augment progesterone-dependent gene expression. Mol Endocrinol Baltim Md 16:2101–2112
Sturm RA, Duffy DL, Zhao ZZ, Leite FPN, Stark MS, Hayward NK, Martin NG, Montgomery GW (2008) A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color. Am J Hum Genet 82:424–431
Sturm RA, Larsson M (2009) Genetics of human iris colour and patterns. Pigment Cell Melanoma Res 22:544–562
Ceccarelli E, McGrew MJ, Nguyen T, Grieshammer U, Horgan D, Hughes SH, Rosenthal N (1999) An E box comprises a positional sensor for regional differences in skeletal muscle gene expression and methylation. Dev Biol 213:217–229
Branzei D, Foiani M (2010) Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol 11:208–219
Unk I, Hajdú I, Fátyol K, Hurwitz J, Yoon J-H, Prakash L, Prakash S, Haracska L (2008) Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination. Proc Natl Acad Sci USA 105:3768–3773
Motegi A, Liaw H-J, Lee K-Y, Roest HP, Maas A, Wu X, Moinova H, Markowitz SD, Ding H, Hoeijmakers JHJ et al (2008) Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks. Proc Natl Acad Sci USA 105:12411–12416
Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182
Ding L, Forsburg SL (2014) Essential domains of Schizosaccharomyces pombe Rad8 required for DNA damage response. G3 Bethesda Md 4:1373–1384
Ortiz-Bazán MÁ, Gallo-Fernández M, Saugar I, Jiménez-Martín A, Vázquez MV, Tercero JA (2014) Rad5 plays a major role in the cellular response to DNA damage during chromosome replication. Cell Rep 9:460–468
Lin J-R, Zeman MK, Chen J-Y, Yee M-C, Cimprich KA (2011) SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis. Mol Cell 42:237–249
Masuda Y, Suzuki M, Kawai H, Hishiki A, Hashimoto H, Masutani C, Hishida T, Suzuki F, Kamiya K (2012) En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2–E3 pairs. Nucleic Acids Res
Krijger PHL, Lee K-Y, Wit N, van den Berk PCM, Wu X, Roest HP, Maas A, Ding H, Hoeijmakers JHJ, Myung K et al (2011) HLTF and SHPRH are not essential for PCNA polyubiquitination, survival and somatic hypermutation: existence of an alternative E3 ligase. DNA Repair 10:438–444
Hendel A, Krijger PHL, Diamant N, Goren Z, Langerak P, Kim J, Reissner T, Lee K, Geacintov NE, Carell T et al (2011) PCNA ubiquitination is important, but not essential for translesion DNA synthesis in mammalian cells. PLoS Genet 7:e1002262
Achar YJ, Balogh D, Haracska L (2011) Coordinated protein and DNA remodeling by human HLTF on stalled replication fork. Proc Natl Acad Sci USA 108:14073–14078
Blastyák A, Hajdú I, Unk I, Haracska L (2010) Role of double-stranded DNA translocase activity of human HLTF in replication of damaged DNA. Mol Cell Biol 30:684–693
Hishiki A, Hara K, Ikegaya Y, Yokoyama H, Shimizu T, Sato M, Hashimoto H (2015) Structure of a novel DNA-binding domain of Helicase-like Transcription Factor (HLTF) and its functional implication in DNA damage tolerance. J Biol Chem 290:13215–13223
Ikegaya Y, Hara K, Hishiki A, Yokoyama H, Hashimoto H (2015) Crystallographic study of a novel DNA-binding domain of human HLTF involved in the template-switching pathway to avoid the replication arrest caused by DNA damage. Acta Crystallogr. Sect F Struct Biol Commun 71:668–670
Kile AC, Chavez DA, Bacal J, Eldirany S, Korzhnev DM, Bezsonova I, Eichman BF, Cimprich KA (2015) HLTF’s ancient HIRAN domain binds 3′ DNA ends to drive replication fork reversal. Mol Cell
Tsutakawa SE, Tainer JA (2015) Bending forks and wagging dogs-It’s about the DNA 3′ tail. Mol Cell 58:972–973
Longerich S, Sung P (2011) Clearance of roadblocks in replication fork restart. Proc Natl Acad Sci USA 108:13881–13882
Burkovics P, Sebesta M, Balogh D, Haracska L, Krejci L (2014) Strand invasion by HLTF as a mechanism for template switch in fork rescue. Nucleic Acids Res 42:1711–1720
Kang MY, Lee BB, Kim Y-H, Chang DK, Kyu Park S, Chun H-K, Song SY, Park J, Kim D-H (2007) Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int J Cancer J Int Cancer 121:2192–2197
Kim Y-H, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD et al (2006) CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 45:781–789
Brandes JC, van Engeland M, Wouters KAD, Weijenberg MP, Herman JG (2005) CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype. Carcinogenesis 26:1152–1156
Bai AHC, Tong JHM, To K-F, Chan MWY, Man EPS, Lo K-W, Lee JFY, Sung JJY, Leung WK (2004) Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer J Int Cancer 112:846–853
Hibi K, Nakayama H, Kanyama Y, Kodera Y, Ito K, Akiyama S, Nakao A (2003) Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer J Int Cancer 104:433–436
Hibi K, Kodera Y, Ito K, Akiyama S, Nakao A (2005) Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis. Dis Colon Rectum 48:1282–1286
Hibi K, Nakao A (2006) Highly-methylated colorectal cancers show poorly-differentiated phenotype. Anticancer Res 26:4263–4266
Lee BB, Lee EJ, Jung EH, Chun H-K, Chang DK, Song SY, Park J, Kim D-H (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin. Cancer Res. Off J Am Assoc Cancer Res 15:6185–6191
Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, Göke B, Lamerz R, Kolligs FT (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res 12:7347–7352
Herbst A, Wallner M, Rahmig K, Stieber P, Crispin A, Lamerz R, Kolligs FT (2009) Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence. Eur J Gastroenterol Hepatol 21:565–569
Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, Ofner A, Crispin A, Neumann J, Lamerz R, Kolligs FT (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106:1110–1118
Philipp AB, Stieber P, Nagel D, Neumann J, Spelsberg F, Jung A, Lamerz R, Herbst A, Kolligs FT (2012) Prognostic role of methylated free circulating DNA in colorectal cancer. Int J Cancer J Int Cancer 131:2308–2319
Philipp AB, Nagel D, Stieber P, Lamerz R, Thalhammer I, Herbst A, Kolligs FT (2014) Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer. BMC Cancer 14:245
Leung WK, To K-F, Man EPS, Chan MWY, Bai AHC, Hui AJ, Chan FKL, Sung JJY (2005) Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 100:2274–2279
Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S et al (2007) Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 5:111–117
Leung WK, To K-F, Man EPS, Chan MWY, Hui AJ, Ng SSM, Lau JYW, Sung JJY (2007) Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 102:1070–1076
Hamai Y, Oue N, Mitani Y, Nakayama H, Ito R, Matsusaki K, Yoshida K, Toge T, Yasui W (2003) DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma. Cancer Sci 94:692–698
Leung WK, Yu J, Bai AHC, Chan MWY, Chan K-K, To K-F, Chan FKL, Ng EKW, Chung SCS, Sung JJY (2003) Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer. Mol Carcinog 37:91–97
Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W (2006) Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106:1250–1259
Kim JJ, Chung SW, Kim JH, Kim JW, Oh JS, Kim S, Song SY, Park J, Kim D-H (2006) Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history. Ann. Oncol. Off J Eur Soc Med Oncol ESMO 17:657–662
Guo W, Dong Z, Guo Y, Chen Z, Kuang G, Yang Z (2011) Aberrant methylation of the CpG island of HLTF gene in gastric cardia adenocarcinoma and dysplasia. Clin Biochem 44:784–788
Fukuoka T, Hibi K, Nakao A (2006) Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res 26:3333–3335
Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP (2006) Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer J Int Cancer 118:2168–2171
Jo H, Kang S, Kim JW, Kang GH, Park NH, Song YS, Park SY, Kang SB, Lee HP (2007) Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer. J Obstet Gynaecol Res 33:236–241
Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, Sánchez-Carbayo M (2010) Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Trans Med 8:86
Zhang X, Li HM, Liu Z, Zhou G, Zhang Q, Zhang T, Zhang J, Zhang C (2013) Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma. J Gastroenterol 48:132–143
García-Baquero R, Puerta P, Beltran M, Alvarez M, Sacristan R, Alvarez-Ossorio JL, Sánchez-Carbayo M (2013) Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study. J Urol 190:723–730
García-Baquero R, Puerta P, Beltran M, Alvarez-Mújica M, Alvarez-Ossorio JL, Sánchez-Carbayo M (2014) Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors. Tumour Biol J Int Soc Oncodevelopmental Biol Med
Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, Henikoff S, Grady WM (2010) Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog 49:94–103
Sandhu S, Wu X, Nabi Z, Rastegar M, Kung S, Mai S, Ding H (2012) Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer 11:18
Debauve G, Nonclercq D, Ribaucour F, Wiedig M, Gerbaux C, Leo O, Laurent G, Journé F, Belayew A, Toubeau G (2006) Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Mol Cancer 5:23
Cho S, Cinghu S, Yu J-R, Park W-Y (2011) Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity. J Cancer Res Clin Oncol 137:629–637
Ye C, Sun N-X, Ma Y, Zhao Q, Zhang Q, Xu C, Wang S-B, Sun S-H, Wang F, Li W (2015) MicroRNA-145 contributes to enhancing radiosensitivity of cervical cancer cells. FEBS Lett 589:702–709
Arcolia V, Paci P, Dhont L, Chantrain G, Sirtaine N, Decaestecker C, Remmelink M, Belayew A, Saussez S (2014) Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers. BMC Cancer 14:492
Debauve G, Capouillez A, Belayew A, Saussez S (2008) The helicase-like transcription factor and its implication in cancer progression. Cell. Mol. Life Sci. CMLS 65:591–604
Masuda T, Hattori N, Senoo T, Akita S, Ishikawa N, Fujitaka K, Haruta Y, Murai H, Kohno N (2013) SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis. Mol Cancer Ther 12:2378–2388
Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8:S62–S67
Walerych D, Napoli M, Collavin L, Del Sal G (2012) The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis 33:2007–2017
Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005–1011
Sun Y, Lou X, Yang M, Yuan C, Ma L, Xie B-K, Wu J-M, Yang W, Shen SX, Xu N et al (2013) Cyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G 2/M phases of the cell cycle. Cell Cycle Georget. Tex 12:3512–3525
Lenzken SC, Loffreda A, Barabino SML (2013) RNA Splicing: a New Player in the DNA Damage Response. Int J Cell Biol 2013:153634
Bond CS, Fox AH (2009) Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol 186:637–644
Acknowledgments
L. D. is a F. R. S.-FNRS Research Fellow (Belgian National Fund for Scientific Research). C. M. was a Télévie Research Associate (Belgian National Fund for Scientific Research). This work was financially supported through funding from F. R. S.-FNRS, Télévie and FRMH (Fonds pour la Recherche Médicale dans le Hainaut, Belgium).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhont, L., Mascaux, C. & Belayew, A. The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?. Cell. Mol. Life Sci. 73, 129–145 (2016). https://doi.org/10.1007/s00018-015-2060-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-015-2060-6